Estela Rodriguez, Associate Director of Community Outreach and Co-Lead of the Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center, shared a post on X:
“WLC25
More targets! Better drugs- Targeted Therapy Session going on now covering the latest in KRAS, BRAF, MET, ROS1, NTRK, ALK, NRG1 fusions lung cancer – and toxicity/benefit of new drugs.”
